Davita Inc vs Warner Music Group Corp — how do they compare? Davita Inc trades at $179.02 (market cap $11.72B), while Warner Music Group Corp trades at $25.08 (market cap $13.82B). The key difference: Warner Music Group Corp is the larger of the two by market cap, and Warner Music Group Corp pays a 3.03% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | WMG | |
|---|---|---|
Market Cap | $11.72B | $13.82B |
Sector | Health | Media |
52-Week High | $240.96 | $34.72 |
52-Week Low | $103.87 | $23.65 |
Enterprise Value | $24.44B | $18.12B |
Dividend Yield | — | 3.03% |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.77, up 1.72% today, with a mixed technical picture showing bearish moving averages but bullish oscillators. The company reported strong Q2 2026 earnings of $4.02 per share, beating estimates, driven by volume growth. Revenue reached $13.64 billion in 2025, with a net income margin of 6.05%. Analyst consensus is a Buy with a $232.25 price target, though technical signals are bearish overall.
The outlook for DVA is cautiously optimistic, supported by earnings beats and volume growth, but risks include reimbursement pressure and high debt levels. The stock offers potential upside to the consensus target, yet investors face headwinds from margin compression and technical bearishness.
Warner Music Group (WMG) trades at $26.39, showing modest daily movement with a slight 0.19% decline. The stock exhibits bearish technical signals despite recent earnings beats in Q1 and Q2 2026. Fundamentally, revenue has grown consistently from $5.9B in 2022 to $6.7B in 2025, though net income margin declined to 5.44%. The company maintains strong profitability metrics with 45.77% gross margin and 25.38% ROE, while analyst sentiment remains positive with 66.7% buy ratings.
WMG presents a compelling value opportunity with reasonable valuation multiples (P/E 21.11, P/S 1.89) and strong analyst support. Near-term catalysts include streaming revenue growth and new licensing partnerships, though risks include margin pressure and leadership transitions. The stock's current technical weakness may offer entry points for long-term investors seeking exposure to music industry consolidation and digital transformation trends.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →